Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention

키워드

참고문헌 (54)

1. Flegal KM, "Prevalence and trends in obesity among US adults, 1999-2008", JAMA, 303, pp.235~241 (2010)
2. Ng M, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013", Lancet, 384, pp.766~781 (2014)
3. Adams KF, "Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old", N Engl J Med, 355, pp.763~778 (2006)
4. Bellentani S, "Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)", Ann Hepatol, 8(Suppl 1), pp.S4~S8 (2009)
5. Adams LA, "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
6. Yanovski SZ, "Long-term drug treatment for obesity: a systematic and clinical review", JAMA, 311, pp.74~86 (2014)
7. Buchwald H, "Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis", Am J Med, 122, pp.248~256 (2009)
8. Schauer PR, "Bariatric surgery versus intensive medical therapy in obese patients with diabetes", N Engl J Med, 366, pp.1567~1576 (2012)
9. Finkelstein EA, "Annual medical spending attributable to obesity: payer-and service-specific estimates", Health Aff, 28, pp.w822~w831 (2009)
10. Frühbeck G, "Fundus functionality and ghrelin concentrations after bariatric surgery", N Engl J Med, 350, pp.308~309 (2004)
11. Phillips RJ, "Gastric volume rather than nutrient content inhibits food intake", Am J Physiol, 271(3 Pt 2), pp.R766~R769 (1996)
12. Wahlen CH, "The bioenterics intragastric balloon (BIB): How to use it", Obes Surg, 11, pp.524~527 (2001)
13. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, "ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastrointest Endosc, 82, pp.425~438 (2015)
14. Abu Dayyeh BK, "A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects", Gastrointest Endosc, 81(5 Suppl), pp.AB147~ (2015)
15. "ORBERA™ Intragastric balloon system-P140008" (2015)[URL]
16. Crea N, "Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis", Obes Surg, 19, pp.1084~1088 (2009)
17. Fuller NR, "An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study", Obesity, 21, pp.1561~1570 (2013)
18. Lee YM, "Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study", Gastrointest Endosc, 76, pp.756~760 (2012)
19. Mui WL, "Impact on obesity-related illnesses and quality of life following intragastric balloon", Obes Surg, 20, pp.1128~1132 (2010)
20. Kotzampassi K, "500 intragastric balloons: what happens 5 years thereafter?", Obes Surg, 22, pp.896~903 (2012)
21. Gómez V, "Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study", Obesity, 24, pp.1849~1853 (2016)
22. Tai CM, "Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal", Obes Surg, 23, pp.2068~2074 (2013)
23. Dumonceau JM, "Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study", Obes Surg, 20, pp.692~697 (2010)
24. Genco A, "Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: a prospective study on 100 patients", Obes Surg, 20, pp.1496~1500 (2010)
25. Genco A, "Effect of consecutive intragastric balloon (BIB®) plus diet versus single BIB® plus diet on eating disorders not otherwise specified (EDNOS) in obese patients", Obes Surg, 23, pp.2075~2079 (2013)
26. Lopez-Nava G, "BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714consecutive patients treated with one or two consecutive balloons", Obes Surg, 21, pp.5~9 (2011)
27. "ReShape integrated dual balloon system-P140012" (2015)[URL]
28. Ponce J, "The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity", Surg Obes Relat Dis, 11, pp.874~881 (2015)
29. Lopez-Nava G, "Dual intragastric balloon: single ambulatory center Spanish experience with 60 patients in endoscopic weight loss management", Obes Surg, 25, pp.2263~2267 (2015)
30. Ponce J, "Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity", Surg Obes Relat Dis, 9, pp.290~295 (2013)
31. Brooks J, "One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K", Obes Surg, 24, pp.813~819 (2014)
32. Genco A, "Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy", Obes Surg, 23, pp.953~958 (2013)
33. "Obalon balloon system-P160001" (2016)[URL]
34. Sullivan S, "The obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6- month randomized sham controlled trial", Gastroenterology, 150(4 Suppl 1), pp.S1267~ (2016)
35. Evzen Machytka, "Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study", Endoscopy, 49(02), pp.154~160 (2017), Georg Thieme Verlag KG[DOI]
36. Marinos G, "Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study", Surg Obes Relat Dis, 10, pp.929~934 (2014)
37. "New endoscopic stent can lead to 100% EWL" (2012)[URL]
38. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity", Gastrointest Endosc, 78, pp.530~535 (2013)
39. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals", Clin Gastroenterol Hepatol, 15, pp.37~43 (2017)
40. Sharaiha RZ, "Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population", Endoscopy, 47, pp.164~166 (2015)
41. Lopez-Nava G, "Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success", Endosc Int Open, 4, pp.E222~E227 (2016)
42. Lopez-Nava G, "Endoscopic sleeve gastroplasty: how I do it?", Obes Surg, 25, pp.1534~1538 (2015)
43. Kumar N, "Endoscopic sleeve gastroplasty: multicenter weight loss results", Gastroenterology, 148(4Suppl 1), pp.S179~ (2015)
44. Lopez-Nava G, "Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up", Gastroenterology, 150(4 Suppl 1), pp.S26~ (2016)
45. Espinós JC, "Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity : the primary obesity surgery endolumenal (POSE) procedure", Obes Surg, 23, pp.1375~1383 (2013)
46. López-Nava G, "The primary obesity surgery endolumenal (POSE)procedure: one-year patient weight loss and safety outcomes", Surg Obes Relat Dis, 11, pp.861~865 (2015)
47. Miller K, "MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after poseSM vs. medical therapy", Obes Surg, 27, pp.310~322 (2017)
48. Sullivan S, "12 Month randomized sham controlled trial evaluating the safety and efficacy of targeted use of endoscopic suture anchors for primary obesity: the ESSENTIAL study", Gastroenterology, 150(4 Suppl 1), pp.S25~S26 (2016)
49. Barham Abu Dayyeh, "Gastric endoscopic remodeling techniques", Techniques in Gastrointestinal Endoscopy, 19(1), pp.22~26 (2017), Elsevier BV[DOI]
50. Vincent Huberty, "Safety and feasibility of an endoluminal-suturing device for endoscopic gastric reduction (with video)", Gastrointestinal Endoscopy, 85(4), pp.833~837 (2017), Elsevier BV[DOI]
51. Christopher C Thompson, "Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial", The American Journal of Gastroenterology, 112(3), pp.447~457 (2016), Springer Nature[DOI]
52. Rubino F, "The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes", Ann Surg, 244, pp.741~749 (2006)
53. Kaplan LM, "EndoBarrier therapy is associated with glycemic improvement, weight loss and safety issues in patients with obesity and type 2 diabetes on oral antihyperglycemic agents", Proceedings of the 76th scientific sessions (2016), American diabetes association
54. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)

관련 논문AI추천